It’s not “floundering.” All 7 drugs are moving forward. There are 5 recent trials that recently completed, so IPIX is between trials. The next round of trials are getting worked through proposals as well as FDA feedback and responses. Management still has plenty of low dilution funding options available, if there is no license, but there will be one soon.
Like boodog, I’m putting my pocket book where my keyboard is: I’m still buying because I know why I’ve continued to buy and hold for months. Anything under $1 will be seen as a huge bargain very, very soon.